The store will not work correctly when cookies are disabled.
2,2-dichloro-N-(2,5-dichlorothiophen-3-ylsulfonyl)-N-p-tolylacetamide
ID: ALA1172361
PubChem CID: 49798553
Max Phase: Preclinical
Molecular Formula: C13H9Cl4NO3S2
Molecular Weight: 433.17
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(N(C(=O)C(Cl)Cl)S(=O)(=O)c2cc(Cl)sc2Cl)cc1
Standard InChI: InChI=1S/C13H9Cl4NO3S2/c1-7-2-4-8(5-3-7)18(13(19)11(15)16)23(20,21)9-6-10(14)22-12(9)17/h2-6,11H,1H3
Standard InChI Key: KUJNSZHVVXSWIC-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
-2.0139 -17.5916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0151 -18.4190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3003 -18.8319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5838 -18.4185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5867 -17.5880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3021 -17.1789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1262 -17.1728 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8422 -17.5826 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.5552 -17.1674 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8454 -18.4076 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5542 -17.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5514 -18.8127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3314 -19.0691 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.8163 -18.4064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3359 -17.7406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6413 -18.4091 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.8823 -19.2953 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.7299 -18.8309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1231 -16.3478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8360 -15.9326 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5929 -15.9380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5960 -15.1130 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.3058 -16.3532 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11 12 2 0
5 6 2 0
6 1 1 0
1 2 2 0
5 7 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 11 1 0
3 4 2 0
14 16 1 0
7 8 1 0
12 17 1 0
2 18 1 0
8 9 2 0
7 19 1 0
4 5 1 0
19 20 2 0
8 10 2 0
19 21 1 0
2 3 1 0
21 22 1 0
8 11 1 0
21 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 433.17 | Molecular Weight (Monoisotopic): 430.8778 | AlogP: 4.89 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.45 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.93 | CX Basic pKa: ┄ | CX LogP: 5.56 | CX LogD: 5.56 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.65 | Np Likeness Score: -1.43 |
References
1. Caridha D, Kathcart AK, Jirage D, Waters NC.. (2010) Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases., 20 (13): [PMID:20627564] [10.1016/j.bmcl.2010.05.039] |